Publication | Open Access
380MO SKB264 (MK-2870) in previously treated hormone receptor-positive (HR+)/ HER2-negative metastatic breast cancer (mBC): Results from a phase I/II, single-arm, basket trial
12
Citations
0
References
2023
Year
No additional data available for this publication yet. Check back later!